Decoy Therapeutics Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
Decoy Therapeutics Inc. (DCOY) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $0 as of 2018-03-31, per its 10-Q filed 2018-05-02.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2018-05-02
- 2018-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $8.19M.
- 2017-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $9.48M.
- 2017-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $8.00M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value |
|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 |
| 2017-12-31 | $8.19M 10-Q · filed 2018-05-02 |
| 2017-09-30 | $9.48M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $8.00M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $27.15M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $16.52M 10-K · filed 2018-03-07 |
| 2016-09-30 | $10.60M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-03 |
| 2016-03-31 | $4.61M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $24.97M 10-K · filed 2017-03-08 |
| 2015-09-30 | $10.00M 10-Q · filed 2015-11-04 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |